SP-0005: The integration of multimodal imaging in the radiation treatment process: pitfalls and challenges von Haustermans, K, Debucquoy, A

Volltext

Comparison of surgical data and survival outcome of rectal cancer patients that need upfront surgery after chemoradiotherapy versus salvage surgery after watch-and-wait von Bulens, P., Debucquoy, A., Joye, I., Wolthuis, A., D’Hoore, A., Van Cutsem, E., Dekervel, J., Sagaert, X., Dresen, R., Vandecaveye, V., Deroose, C., Haustermans, K.

Volltext

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial von Verstraete, M, Debucquoy, A, Dekervel, J, van Pelt, J, Verslype, C, Devos, E, Chiritescu, G, Dumon, K, D'Hoore, A, Gevaert, O, Sagaert, X, Van Cutsem, E, Haustermans, K

Volltext

SP-0523 THE IMPORTANCE OF RAS MUTATIONS FOR TARGETED THERAPY IN COLON CANCER von Haustermans, K, Debucquoy, A

Volltext

PV-0122: Clinical factors as a selection tool for organ-preserving treatment strategies in rectal cancer von Joye, I, Debucquoy, A, Fieuws, S, Wolthuis, A, D'Hoore, A, Haustermans, K

Volltext

OC-0239: Survival of clinical stage I-III rectal cancer patients: a population-based comparison von Joye, I, Silversmit, G, Van Eycken, E, Debucquoy, A, Vandendael, T, Penninckx, F, Haustermans, K

Volltext

EP-1282: Does blood glucose level normalisation improve PET-based response prediction in rectal cancer? von Joye, I, Debucquoy, A, Wolthuis, A, D'Hoore, A, Van Cutsem, E, Vandecaveye, V, Sagaert, X, Deroose, C, Haustermans, K

Volltext

Does Integrating Functional Imaging and Molecular Markers Contribute to a Better Prediction of the Tumoral Response After Preoperative Chemoradiation Therapy for Rectal Cancer? von Joye, I, Debucquoy, A, Deroose, C.M, Vandecaveye, V, Van Cutsem, E, Wolthuis, A, D'Hoore, A, Sagaert, X, Gevaert, O, Haustermans, K

Volltext

A new approach to the validation of tissue microarrays von Goethals, L, Perneel, C, Debucquoy, A, De Schutter, H, Borghys, D, Ectors, N, Geboes, K, McBride, WH, Haustermans, KM

Volltext

EP-2055: Fibro-inflammatory circulating proteins as biomarkers for response in locally advanced rectal cancer von Bulens, P, Debucquoy, A, Joye, I, De Wever, O, Wolthuis, A, D'Hoore, A, Van Cutsem, E, Vandecaveye, V, Sagaert, X, Deroose, C, Gevaert, O, Haustermans, K

Volltext

PD-0429: Combining chemoradiation with COX-2 inhibitors in rectal cancer: clinical and translational data of a phase II study von Debucquoy, A, Van Cutsem, E, Geboes, K, Penninckx, F, D'Hoore, A, Haustermans, K

Volltext

2070 Is PREDIST-based response assessment an accurate selection tool for organ-preserving strategies after chemoradiotherapy for rectal cancer? von Joye, I, Debucquoy, A, Haustermans, K, Wolthuis, A, D'Hoore, A, Van Cutsem, E, Vandecaveye, V, Sagaert, X, Palmans, S, Deroose, C

Volltext

OC-0019: The role of functional imaging and molecular markers for organ-preserving strategies after CRT for rectal cancer von Joye, I, Debucquoy, A, Deroose, C, Vandecaveye, V, Sagaert, X, Palmans, S, D'Hoore, A, Wolthuis, A, Van Cutsem, E, Haustermans, K

Volltext

Seasonal Cycles in the Germination Capacity of Buried Seeds of Some Leguminosae (Fabaceae) von Van Assche, Jozef A., Katrien L. A. Debucquoy, Wouter A. F. Rommens

Volltext

OC-0253: Bevacizumab with chemoradiation in rectal cancer: clinical and translational results of the AXEBeam trial von Verstraete, M, Debucquoy, A, Dekervel, J, Van Pelt, J, Chiritescu, G, Dumon, K, D'Hoore, A, Sagaert, X, Van Cutsem, E, Haustermans, K

Volltext

MO-0795 Development of a patient decision aid for rectal cancer patients with clinical complete response von Smets, L., Debucquoy, A., Oldenburger, E., Debrun, L., Dekervel, J., D'Hoore, A., Wolthuis, A., Haustermans, K.

Volltext

OC-07: Clinical and Molecular Effects of Treatment with Bevacizumab, Capecitabine and Oxaliplatin in Rectal Cancer von Verstraete, M, Debucquoy, A, Devos, E, Chiritescu, G, Dumon, K, Machiels, J.P, Penninckx, F, Sagaert, X, Van Cutsem, E, Haustermans, K

Volltext

PD-0568 PHASE II STUDY OF NEO ADJUVANT TREATMENT WITH AVASTIN, XELODA AND ELOXATIN IN RECTAL CANCER (AXE BEAM) von Debucquoy, A, Verstraete, M, Chiritescu, G, Dumon, K, Vergauwe, P, Machiels, J.P, Penninckx, F, Sagaert, X, Van Cutsem, E, Haustermans, K

Volltext

EP-2308: Inhibition of lipogenesis: a promising approach to optimise the treatment of rectal cancer von Bulens, P., Debucquoy, A., Swinnen, J., Haustermans, K.

Volltext

Extending the Minimum Information About BIobank Data Sharing Terminology to Describe Samples, Sample Donors, and Events von Eklund, Niina, Andrianarisoa, Ny Haingo, van Enckevort, Esther, Anton, Gabriele, Debucquoy, Annelies, Müller, Heimo, Zaharenko, Linda, Engels, Cäcilia, Ebert, Lars, Neumann, Michael, Geeraert, Joachim, T'Joen, Veronique, Demski, Hans, Caboux, Élodie, Proynova, Rumyana, Parodi, Barbara, Mate, Sebastian, van Iperen, Erik, Merino-Martinez, Roxana, Quinlan, Philip R, Holub, Petr, Silander, Kaisa

Volltext